Awakening the Dormant Therapies Act
Marcelo Barros is a J.D. Candidate, 2021 at NYU School of Law. The Patent System has a Persistent Drug Problem The U.S.’s current regime of patent laws fails to adequately address a problem affecting...
Category: Patent
Slipping Through the Cracks: Limited legal means for developers to protect the ideas behind their apps
Ashley Ulrich is a J.D. candidate, 2021 at NYU School of Law. Introduction Recent news articles have documented Apple’s use of its App Store to identify and copy ideas from best-performing third-party applications. Apple...
Artificial Intelligence as an Inventive Tool and Its Implication to the PHOSITA Standard
Daniel Y. Lee is a J.D. Candidate, 2021 at NYU School of Law. The age of AI-inventors may already be here. This year saw the first patent applications filed in the name of an...
Draft Bill to Overhaul what is Eligible for a Patent
Magdalena Christoforou is a J.D. candidate, 2021 at NYU School of Law. On May 22, 2019, a bipartisan group of lawmakers unveiled a draft bill to rewrite the law on what is patentable subject...
Strawberry Patent Wars Forever
To a casual grocery shopper, looking to find the perfect topping for her shortcake, ingredient for her smoothie or vehicle for her heavenly chocolate fondue, patents are probably the last things on her mind....
Supreme Court to Hear Case on AIA “Secret Sales.”
What is the America Invents Act (AIA)? The path to patentability has many obstacles, and inventors’ own actions sometimes stand in the way of the U.S. Patent and Trademark Office (USPTO) granting a patent...
The Impending Arrival of Newly Proposed Patent Subject Matter Eligibility Guidelines: An Opportunity for Clarity?
On April 11, 2018, the Director of the United States Patent and Trademark Office (USPTO), Andrei Iancu, delivered remarks at the United States Chamber of Commerce Patent Policy Conference, stating that the law surrounding...
Appeals from PTAB to the Federal Circuit: Injury-In-Fact Standing Requirement
There is a long-awaited clarification with regards to the question of whether a petitioner could appeal an adverse decision in an inter partes review (“IPR”) proceeding in the Patent Trials and Appeals Board (“PTAB”) to...
CRISPR Systems: Natural Occurrences & the Trans-Atlantic Divide over Patent Rights
Clorox sells a product, “disinfecting wipes,” that boasts on its container, “Kills 99.9% of Viruses & Bacteria.” It’s a great product, and I use it every day. But it’s a good thing there’s plenty...
Oil States: SCOTUS Preserves IPR Status Quo
On April 24, 2018, the Supreme Court of the United States, in a 7-2 majority, decided Oil States Energy Services v. Greene’s Energy Group, holding that Inter Partes Review (IPR) proceedings do not violate...
